The present invention generally relates to a device and method for determining the quality and effort of respiration and the respiratory rate (RR) of a subject. More particularly, the present invention pertains to a wireless device and method for obtaining an index presenting the probability of deterioration of the respiration.
Respiration is fundamental for life. The lungs are responsible for respiration, the process of supplying oxygen to the body and removing carbon dioxide from the body. Respiratory distress results from failure of oxygenation (insufficient inhalation of oxygen), or failure of ventilation (insufficient removal of carbon dioxide).
These forms of failure can be characterized by irregular breathing rate and/or abnormal breathing patterns. The continuous monitoring of RR and pattern is crucial for detecting the onset of respiratory failure; however, most hospital wards fail to correctly monitor this vital sign. When RR is measured, it is done infrequently. Patients in the general ward are typically checked only once every six to eight hours and often with significant human error, due to the fact that normally the nurse watches the patient breathe for 15 s and then multiply the result by 4 in order to get the RR per min. The World Health Organization promotes to count the number of breaths in one minute. If the RR is higher or lower than the accepted range of 12-16 breaths/min it suggests respiratory issues.
Current devices for measuring RR are very expensive and are connected to the patient with cables, hence they are only used in specialized units such as the Intensive Care Units (ICU).
Twenty-one percent of the patients with RR between 25 and 29/min die in the hospital (Respiratory rate: the neglected vital sign. Michelle A Cretikos, Rinaldo Bellomo, Ken Hillman, Jack Chen, Simon Finfer and Arthas Flabouris. MIA 2008; 188:657-659) The best way to alert the clinical state of the patient and reduce the complications are RR and tidal volume (TV) continuous monitoring. The Corona virus pandemic (Covid-19) has made it clear that respiratory monitoring is necessary outside the hospital setting in nursing homes and even in a home care setting.
The US patent application, “Acoustic sensor and ventilation monitoring system”, US 2020/0054277 A1, by Joseph et al., discloses a method of monitoring respiration with an acoustic measurement device. After an extensive description of the respiratory physiopathology the authors present a device integrated by two elements. One of them is attached to the patient while the second element is attached to the first element. The first element consists of a sound transducer, an accelerometer and a transmitter. The second element consists of a rechargeable battery. In the device several sensors can be integrated to measure temperature, heart rate and oxygen saturation. It could also be connected to a smart watch. With the information from the different sensors they propose a risk factor index to determine the function of the respiration of a mammalian due to physiopathological alterations and drugs or alcohol abuse. They describe a quadratic equation to calculate their respiratory risk factor index. The main differences with our present patent application are on one hand that Joseph et al. use the accelerometer only to assess the body movement while we use the accelerometer for estimation of the respiratory frequency and on the other hand the formulas for respiratory risk index and smart respiratory index are significantly different. Additionally, in the patent application by Joseph et al. the respiratory rate is estimated by the breath acoustics while in the present patent application the respiratory rate is estimated by the thoracic acceleration measured by the accelerometer and the first derivative of the breath sound envelope.
Both the patent application by Joseph and the present patent application use sensors as microphones and accelerometers to assess the sound of breathing and the movement. However, the parameters analyzed in the two works and the derived formula to calculate the risk factor index by Joseph et al and the SRI in the present disclosure are completely different. Joseph et al use the accelerometer to assess the body movement of the patient while in this disclosure the accelerometer is used to calculate the respiratory rate.
Joseph et al use the breath sounds to calculate the respiratory rate and the TV and in this disclosure is used the envelope to assess the variability of the TV.
Finally, for Joseph et al the body movements and the speech add up the highest score while the bradypnea and the lack of movements have the lowest possible score.
The US application, “Portable device with multiple integrated sensors for vital signs scanning”, US2015/0313484 A1, discloses a portable device with multiple integrated sensors. The present patient application is different as it does not use neither thermometer nor photoplethy smogram (PPG) and the present application defines an index of the quality of respiration.
The US application, “Mobile frontend system for comprehensive cardiac diagnosis.” US2015/0065814 A1 is significantly different from the present patent application because the purpose of US2015/0065814 is comprehensive diagnosis of heart issues.
The US patent application, “Mesh network personal emergency appliance” US 2008/0001735 A1 discloses a system that includes one or more wireless nodes forming a wireless mesh network, the present application is different as it does not form a wireless mesh network.
The US patent application, “Monitoring, predicting and treating clinical episodes”, JS2008/0275349 A1”, discloses a device for sensing a physiological parameter of a subject and to sense large body movements, this is significantly different from the present patent application which does not disclose sensing of large body movements. The US application, “Physiological acoustic monitoring system, U.S. Pat. No. 8,821,415B2 United States, is 25 disclosing a method to use acoustic signals to assess the respiratory rate, however they only use one or two acoustic sensors (microphones), hence the present application is totally different as electrocardiogram (ECG) and an accelerometer are used as well.
The US patent METHODS AND SYSTEMS FOR MONITORING RESPIRATION U.S. Pat. No. 6,918,878B2 discloses a method for determining respiration rate in a patient including various parts. The respiration rate can be determined by measuring the heart's S2 split. The S2 split can be identified by observing the timing of the heart sounds. Other respiration related information, such as respiration phase and the occurrence of apnea, can be identified as well A respiration monitor of this type may be useful for monitoring sub-acute patients, and outpatients. A sensor for the respiration monitor and an electrode for an ECG monitor may be combined into a single probe. The present patent application does not include the S2 split and is hence different from U.S. Pat. No. 6,918,878 patent application. The US patent, “System and method for monitoring respiratory rate measurements”, US 2018/0214090 A1, disclose systems and methods for using multiple physiological parameter inputs to determine multiparameter confidence in respiratory rate measurements. This disclosure is different from the present patent application as breath acoustic and ECG R-R interval variation (Rpeaks) is combined in the present application.
In a preferred embodiment a patch (1, 13, 27, 42) containing sensors for at least electrocardiogram (ECG), Respiratory Rate (RR) measured by an accelerometer, RR measured by a microphone is attached to the thorax of the patient. The ECG (2, 14, 29) is further processed with a heart rate (HR) extraction algorithm, for example but not necessarily a Fast Fourier Transform (FFT) (6, 19, 34) to extract the HR of the ECG and the Rpeaks (7, 20, 35) are determined by FFT as well (spectral analysis). The breath sounds (breathing acoustics) from the microphone (3, 15, 30) are subjected to an envelope wave form respiration extraction formula (8, 21, 36) to obtain the respiratory rate, termed RespR. The formula (9, 22, 37) is used to calculate the tidal volume variability (TVv). The acceleration signal of the thorax (4, 16, 31) is analyzed by a Hilbert Transform model which estimates the respiration, termed RespRacc (10, 23, 38). The relationship among the three parameters, Rpeaks, RespR and RespRacc might change as the respiration is deteriorating, therefore the Cross Mutual information (5, 18, 32) is calculated and generating the variable CMIbreath. The parameters extracted from the measurements are fed into a classifier, which could, but not necessarily, be an Adaptive Neuro Fuzzy Inference System (ANFIS) (11, 25, 40). The output of the classifier is termed the Smart Respiratory Index (SRI) (12, 26, 41).
The acoustic signal recorded from the microphone is entered into a spline or other curve function which allows to assess the envelope of the amplitude, Aenvelope, as shown in
Previously, the relationship between respiratory airflow, F, and the energy of breath (tracheal) sound, E, was best fitted by a power law of the form A=kF” where k and a are constants, where different values have been suggested for the exponent by different research groups. This sound's amplitude-airflow relationship has been exploited for breathing monitoring, particularly for qualitative and quantitative assessment of respiratory airflow and for continuous respiratory rate estimation.
However, we found that the estimation can be improved by adding the derivative of the envelope of the breath sound to the equation, hence the following equation for flow is defined:
Consequently, the volume can be estimated as the integral of the airflow F over the time of inspiration,
TV=∫insp startinsp endFdt
The tidal volume variability is here defined as the changes over time, for example if the tidal volume increases from 10 to 12 then the tidal volume variability is 20%.
A new approach using the Hilbert vibration decomposition (I-IVD) for extracting the respiration from the acceleration signal is proposed. It is suggested that the largest energy component of the acceleration signal acquired is proportional to the respiratory signal.
In one embodiment the SRI is a function, linear or quadratic, of the RespR, HR, RRv and TVv. The formula could be,
In the quadratic equation more quadratic factors could be included.
The constants, k1 to k4, should be in the following range:
In a second embodiment the device uses a classifier such as, but not necessarily, an ANFIS model to combine the parameters, for the definition of the SRI, as shown in
In a fourth embodiment the device uses ANFIS models to combine the parameters, for the definition of the SRI, as shown in
ANFIS is a hybrid between a fuzzy logic system and a neural network, it does not assume any mathematical function governing the relationship between input and output. ANFIS applies a data driven approach where the training data decides the behaviour of the system.
The five layers of ANFIS have the following functions
Standard learning procedures from neural network theory are applied in ANFIS. Back-propagation is used to learn the antecedent parameters, i.e the membership functions, and least squares estimation is used to determine the coefficients of the linear combinations in the rules' consequents. A step in the learning procedure has two passes. In the first pass, the forward pass, the input patterns are propagated, and the optimal consequent parameters are estimated by an iterative least mean squares procedure, while the antecedent parameters are fixed for the current cycle through the training set. In the second pass, the backward pass, the patterns are propagated again, and in this pass back-propagation is used to modify the antecedent parameters, while the consequent parameters remain fixed. This procedure is then iterated through the desired number of epochs if the antecedent parameters initially are chosen appropriately, based on expert knowledge, one epoch is often sufficient as the LMS algorithm determines the optimal consequent parameters in one pass and if the antecedents do not change significantly by use of the gradient descent method, neither will the LMS calculation of the consequents lead to another result. For example in a 2-input, 2-rule system, rule 1 is defined by
where p, q and r are linear, termed consequent parameters or only consequents. Most common is f of first order as higher order Sugeno fuzzy models introduce great complexity with little obvious merit.
The inputs to the ANFIS system are fuzzified into a number of predetermined classes. The number of classes should be larger or equal to two. The number of classes can be determined by different methods. In traditional fuzzy logic the classes are defined by an expert. The method can only be applied if it is evident to the expert where the landmarks between two classes can be placed. ANFIS optimizes the position of the landmarks, however the gradient descent method will reach its minimum faster if the initial value of the parameters defining the classes is close to the optimal values. By default, ANFIS initial landmarks are chosen by dividing the interval from minimum to maximum of all data into n equidistant intervals, where n is the number of classes. The number of classes could also be chosen by plotting the data in a histogram and visually deciding for an adequate number of classes, by ranking as done by fuzzy inductive reasoning (FIR), through various clustering methods or Markov models. The ANFIS default was chosen for this invention and it showed that more than 3 classes resulted in instabilities during the validation phase, hence either 2 or 3 classes were used.
Both the number of classes and number of inputs add to the complexity of the model i.e. the number of parameters. For example, a system with 4 inputs, each fuzzified into 3 classes consists of 36 antecedent (non-linear) and 405 consequent (linear) parameters, calculated by the following two formulas:
The number of input-output pairs should in general be much larger, (at least a factor 10) than the number of parameters in order to obtain a meaningful solution of the parameters.
Unfortunately there exists no definition of stability criteria for neuro-fuzzy systems. The most useful tool for ensuring stability is the experience obtained by working with a certain neuro-fuzzy system such as ANFIS in the context of a particular data set, and testing with extreme data for example obtained by simulation.
ANFIS uses a Root Mean Square Error (RMSE) to validate the training result and from a set of validation data the RMSE validation error can be calculated after each training epoch. One epoch is defined as one update of both the antecedent and the consequent parameters. An increased number of epochs will in general decrease the training error.
Number | Date | Country | Kind |
---|---|---|---|
PA 2020 01182 | Oct 2020 | DK | national |
Number | Date | Country | |
---|---|---|---|
Parent | PCT/IB21/59526 | Oct 2021 | WO |
Child | 18298399 | US |